Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Conjumab-A (IN-N01-OX2, N01-OX2)
print preview
bookmark
share with colleague
General Information
Company
Intellect Neurosciences Inc.
Description
Humanized IgG4 mAb targeting beta amyloid conjugated to OX2, a small molecule anti-oxidant and protein aggregation inhibitor
Molecular Target
Mechanism of Action
Antibody-drug conjugate
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Disease Category
Standard Indication
Indication Details
Partners
Milestones
Latest Stage of Development
More
Archive Items are loading
Set Email Alert
dummy